Why Apollo Hospitals Share Price Tumbled?


by Sandip Das on 29 April 2024,  3 min read


Shares of Apollo Hospitals Enterprise experienced an 8 percent decline in opening trade on April 29, reflecting investor apprehension regarding the valuations attributed to the company’s subsidiary, Apollo HealthCo, following its recent agreement with Advent International, according to a moneycontrol.com report.

Apollo HealthCo, the managing entity behind Apollo 24/7 vertical, announced a substantial capital infusion of Rs 2,475 crore from global private equity investor Advent International. Additionally, it unveiled plans for a complete merger with wholesale pharmaceutical distributor Keimed Private Ltd over the next 24-30 months.

As per the agreement, Advent International will secure a 12.1 percent stake in the merged entity, valuing it at an enterprise value of Rs 22,481 crore. Notably, Apollo 24/7 commands a valuation of Rs 14,478 crore, while Keimed is valued at Rs 8,003 crore within this consolidated entity.

The crux of investor concern lies in the valuation attributed to Apollo 24/7. Market observers, including Nuvama Institutional Equities, expressed reservations regarding the perceived undervaluation of Apollo HealthCo’s flagship platform. Despite acknowledging the long-overdue nature of the deal, Nuvama raised eyebrows at the $1.7 billion valuation assigned to Apollo 24/7, considering it notably lower than the estimated $2.7 billion. Such a disparity not only caught investors by surprise but also cast doubt on the aggressiveness of doubling Keimed’s valuation within a year.

Also read: What is a Demat Account?

In response to these concerns, Apollo Hospitals management conceded that Apollo 24/7 did not receive the valuation it warranted. Consequently, Nuvama Institutional Equities revised downwards its price target for Apollo Hospitals by approximately 3 percent to Rs 7,300, while maintaining its “buy” recommendation.

The market’s reaction to this development underscores the critical role of accurate valuation in investor sentiment. While the strategic partnership with Advent International presents significant growth opportunities for Apollo HealthCo, the perceived undervaluation of Apollo 24/7 has cast a shadow over the deal’s immediate impact on Apollo Hospitals’ stock performance.

However, it’s essential to contextualize this market response within the broader landscape of healthcare investments and strategic partnerships. Despite the short-term market turbulence, the long-term implications of this collaboration may yet unfold in favor of Apollo Hospitals and its stakeholders.

In navigating this scenario, it becomes imperative for Apollo Hospitals to address investor concerns transparently while emphasizing the strategic rationale behind the deal with Advent International. Clear communication regarding the growth trajectory of Apollo HealthCo and its synergies with Apollo Hospitals’ broader business portfolio can help restore investor confidence over time.

Moreover, proactive measures to enhance the operational efficiency and value proposition of Apollo 24/7 could serve to bridge the valuation gap and align market expectations with the company’s growth prospects. This may involve strategic initiatives such as expanding service offerings, optimizing customer acquisition channels, and leveraging technological innovations to drive market penetration and revenue growth.

From a broader industry perspective, the evolving landscape of healthcare investments underscores the growing importance of digital health platforms and innovative healthcare delivery models. As the healthcare sector continues to undergo rapid transformation fueled by technological advancements and changing consumer preferences, strategic partnerships and investments play a pivotal role in shaping the competitive dynamics and market positioning of industry players.

While the initial market reaction to the Apollo HealthCo-Advent International deal may have triggered short-term volatility in Apollo Hospitals’ stock performance, the long-term implications of this strategic partnership warrant careful consideration. By addressing investor concerns, optimizing operational performance, and leveraging growth opportunities within the digital health space, Apollo Hospitals can navigate the current challenges and emerge stronger in the evolving healthcare landscape.

Source: moneycontrol

Dhanush powered by Ashika Group, is one of the best online trading app in India which gives a flawless and smooth trading experience. Get solid research analysis, data-driven approach, customer-centric service philosophy, trust-based advice & competitively priced products. Click here for more stock market blogs.

For more insightful articles and updates, follow us on Facebook and Instagram.

Disclaimer: The information provided in this blog post is for informational purposes only and should not be construed as investment or trading advice. The author is not a financial advisor and does not have any professional qualifications in this area. The author does not guarantee the accuracy or completeness of the information provided. Any action you take based on the information in this blog post is done at your own risk. Please consult with a financial advisor before making any investment.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Spread the love